Beta Bionics, Inc.
BBNX
$22.26
$1.778.64%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 23.24M | 17.64M | 20.44M | 16.71M | 15.05M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.24M | 17.64M | 20.44M | 16.71M | 15.05M |
| Cost of Revenue | 10.74M | 8.67M | 8.75M | 7.79M | 6.96M |
| Gross Profit | 12.50M | 8.97M | 11.69M | 8.91M | 8.08M |
| SG&A Expenses | 23.50M | 20.02M | 15.51M | 14.75M | 13.52M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 43.11M | 36.28M | 33.48M | 27.68M | 26.83M |
| Operating Income | -19.87M | -18.64M | -13.04M | -10.98M | -11.78M |
| Income Before Tax | -16.87M | -28.66M | -18.11M | -9.74M | -14.46M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -16.87M | -28.66M | -18.11M | -9.74M | -14.46M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.87M | -28.66M | -18.11M | -9.74M | -14.46M |
| EBIT | -19.87M | -18.64M | -13.04M | -10.98M | -11.78M |
| EBITDA | -19.53M | -18.34M | -12.81M | -10.67M | -11.49M |
| EPS Basic | -0.39 | -0.93 | -2.72 | -1.55 | -2.37 |
| Normalized Basic EPS | -0.24 | -0.58 | -1.70 | -0.97 | -1.48 |
| EPS Diluted | -0.39 | -0.93 | -2.72 | -1.55 | -2.37 |
| Normalized Diluted EPS | -0.24 | -0.58 | -1.70 | -0.97 | -1.48 |
| Average Basic Shares Outstanding | 43.39M | 30.71M | 6.67M | 6.26M | 6.11M |
| Average Diluted Shares Outstanding | 43.39M | 30.71M | 6.67M | 6.26M | 6.11M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |